Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MYBL2 | hg38_v1_chr20_+_43667105_43667125, hg38_v1_chr20_+_43667019_43667098 | -0.18 | 6.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_157436842 Show fit | 1.32 |
ENST00000295927.4
|
pentraxin 3 |
|
chr3_+_99638475 Show fit | 1.09 |
ENST00000452013.5
ENST00000261037.7 ENST00000652472.1 ENST00000273342.8 ENST00000621757.1 |
collagen type VIII alpha 1 chain |
|
chr1_+_163068775 Show fit | 0.94 |
ENST00000421743.6
|
regulator of G protein signaling 4 |
|
chr14_+_103928432 Show fit | 0.74 |
ENST00000409874.9
|
tudor domain containing 9 |
|
chr8_-_119673368 Show fit | 0.63 |
ENST00000427067.6
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
chr4_-_165279679 Show fit | 0.62 |
ENST00000505354.2
|
glycerol kinase 3 pseudogene |
|
chr2_-_68319887 Show fit | 0.61 |
ENST00000409862.1
ENST00000263655.4 |
cannabinoid receptor interacting protein 1 |
|
chr3_-_112638097 Show fit | 0.58 |
ENST00000461431.1
|
coiled-coil domain containing 80 |
|
chr12_+_104303726 Show fit | 0.56 |
ENST00000527879.2
|
EP300 interacting inhibitor of differentiation 3 |
|
chr9_-_76692181 Show fit | 0.52 |
ENST00000376717.6
ENST00000223609.10 |
prune homolog 2 with BCH domain |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
0.0 | 1.1 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 1.0 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.9 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.7 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.0 | 0.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.5 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.3 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 1.1 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.7 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.4 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 1.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.8 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |